Mark Neumann

Executive Vice President, Chief Commercial Officer

Professional Overview

Mark Neumann is an accomplished pharmaceutical executive with over 35 years of experience driving commercial strategy and growth across multiple therapeutic areas, including cardiovascular, neuroscience, bone health, inflammation, and nephrology. As the Executive Vice President and Chief Commercial Officer at Intra-Cellular Therapies, he is responsible for leading the company's global commercial operations and propelling the market success of its innovative drug portfolio.

Experience Summary

Current Role

As the Executive Vice President and Chief Commercial Officer at Intra-Cellular Therapies, Mark is responsible for developing and executing the company's global commercial strategy. He oversees all aspects of commercialization, including market access, brand management, sales, and customer engagement, to ensure the successful launch and growth of Intra-Cellular's products. Under his leadership, the company has achieved significant commercial milestones and expanded its reach in the pharmaceutical industry.

Career Progression

Prior to joining Intra-Cellular Therapies, Mark held various senior-level marketing and sales positions at leading pharmaceutical companies, including Amgen and Bristol-Myers Squibb. At Amgen, he served as the Vice President of Global Marketing and Therapeutic Area Head for Bone Health, Inflammation, and Nephrology, where he led the commercialization of key products and drove global brand strategies. At Bristol-Myers Squibb, he held leadership roles across multiple therapeutic areas, including cardiovascular, neuroscience, and diabetes, demonstrating his ability to navigate complex and dynamic market environments.

Academic Background

Mark holds an AB in Economics and Business Administration from Lafayette College, where he honed his analytical and strategic decision-making skills.

Areas of Expertise

Pharmaceutical commercialization and product launch strategy

Global brand management and marketing

Sales force optimization and customer engagement

Therapeutic area expertise in cardiovascular, neuroscience, bone health, inflammation, and nephrology

Cross-functional leadership and team building

Professional Impact

Throughout his career, Mark has consistently delivered impressive results and made significant contributions to the pharmaceutical industry. His strategic vision, data-driven approach, and strong leadership have enabled him to drive market share growth, improve patient access, and enhance the commercial performance of multiple blockbuster products. Mark's deep industry knowledge, coupled with his ability to navigate complex regulatory environments and collaborate effectively with cross-functional teams, have positioned him as a respected and influential leader in the pharmaceutical sector.

Conclusion

With his extensive experience, strategic acumen, and proven track record of success, Mark Neumann is well-equipped to lead Intra-Cellular Therapies' commercial operations and contribute to the company's continued growth and expansion in the pharmaceutical industry.